{ "@graph": [    { "@id": "http://linked.opendata.cz/resource/ATC/G",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "GENITO URINARY SYSTEM AND SEX HORMONES" , "@language" : "en" } ,        { "@value" : "Urogenit\u00E1ln\u00ED trakt a pohlavn\u00ED hormony" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "G" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/G04",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "UROLOGICALS" , "@language" : "en" } ,        { "@value" : "Urologika" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "G04" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/G04C",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "L\u00E9\u010Diva k terapii benign\u00ED hyperplazie prostaty" , "@language" : "cs" } ,        { "@value" : "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "G04C" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/G04CB",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Inhibitory testosteron-5-alfa redukt\u00E1zy" , "@language" : "cs" } ,        { "@value" : "Testosterone-5-alpha reductase inhibitors" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "G04CB" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/G04CB02",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://www.w3.org/2004/02/skos/core#broaderTransitive" : [ "http://linked.opendata.cz/resource/ATC/G04" ,        "http://linked.opendata.cz/resource/ATC/G" ,        "http://linked.opendata.cz/resource/ATC/G04C" ,        "http://linked.opendata.cz/resource/ATC/G04CB" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Dutasterid" , "@language" : "cs" } ,        { "@value" : "Dutasteride" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "G04CB02" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Drug hypersensitivity" , "@language" : "en" } ,        { "@value" : "L\u00E9kov\u00E1 alergie" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000010205",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "D\u00EDt\u011B" , "@language" : "cs" } ,        { "@value" : "Child" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000010200",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Female" , "@language" : "en" } ,        { "@value" : "\u017Densk\u00E9 pohlav\u00ED" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0281571",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/Ingredient" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Dutasteride" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPregnancyCategory" : [ "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/X" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/contraindicatedWith" : [ "http://linked.opendata.cz/resource/ndfrt/disease/N0000010205" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000010200" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product/AVODART-0-5-MG",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProduct" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasActiveIngredient" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0281571" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "AVODART 0,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/G04CB02" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPregnancyCategory" : [ "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/X" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMedicinalProductPackaging" : [ "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0016902" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0016903" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0016904" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0118331" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0118330" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0118331",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "AVODART 0,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/G04CB02" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "VARIA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC148507_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "60" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "0.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Terapie st\u0159edn\u011B t\u011B\u017Ek\u00FDch a\u017E t\u011B\u017Ek\u00FDch p\u0159\u00EDznak\u016F benign\u00ED hyperplazie prostaty (BHP).\nSn\u00ED\u017Een\u00ED rizika akutn\u00ED retence mo\u010Di (ARM) a chirurgick\u00E9ho v\u00FDkonu u pacient\u016F se st\u0159edn\u011B t\u011B\u017Ek\u00FDmi a\u017E t\u011B\u017Ek\u00FDmi p\u0159\u00EDznaky BHP. \nPro informace o \u00FA\u010Dinc\u00EDch l\u00E9\u010Dby a souborech pacient\u016F zkouman\u00FDch v\u00A0klinick\u00FDch studi\u00EDch nahl\u00E9dn\u011Bte, pros\u00EDm, do bodu 5.1.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR CPS MOL 60X0.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0118330",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "AVODART 0,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/G04CB02" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "VARIA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC148507_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "50" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "0.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Terapie st\u0159edn\u011B t\u011B\u017Ek\u00FDch a\u017E t\u011B\u017Ek\u00FDch p\u0159\u00EDznak\u016F benign\u00ED hyperplazie prostaty (BHP).\nSn\u00ED\u017Een\u00ED rizika akutn\u00ED retence mo\u010Di (ARM) a chirurgick\u00E9ho v\u00FDkonu u pacient\u016F se st\u0159edn\u011B t\u011B\u017Ek\u00FDmi a\u017E t\u011B\u017Ek\u00FDmi p\u0159\u00EDznaky BHP. \nPro informace o \u00FA\u010Dinc\u00EDch l\u00E9\u010Dby a souborech pacient\u016F zkouman\u00FDch v\u00A0klinick\u00FDch studi\u00EDch nahl\u00E9dn\u011Bte, pros\u00EDm, do bodu 5.1.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR CPS MOL 50X0.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0016902",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "AVODART 0,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/G04CB02" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "VARIA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC148507_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "10" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "0.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Terapie st\u0159edn\u011B t\u011B\u017Ek\u00FDch a\u017E t\u011B\u017Ek\u00FDch p\u0159\u00EDznak\u016F benign\u00ED hyperplazie prostaty (BHP).\nSn\u00ED\u017Een\u00ED rizika akutn\u00ED retence mo\u010Di (ARM) a chirurgick\u00E9ho v\u00FDkonu u pacient\u016F se st\u0159edn\u011B t\u011B\u017Ek\u00FDmi a\u017E t\u011B\u017Ek\u00FDmi p\u0159\u00EDznaky BHP. \nPro informace o \u00FA\u010Dinc\u00EDch l\u00E9\u010Dby a souborech pacient\u016F zkouman\u00FDch v\u00A0klinick\u00FDch studi\u00EDch nahl\u00E9dn\u011Bte, pros\u00EDm, do bodu 5.1.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR CPS MOL 10X0.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0016903",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "AVODART 0,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/G04CB02" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "VARIA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC148507_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "30" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "0.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Terapie st\u0159edn\u011B t\u011B\u017Ek\u00FDch a\u017E t\u011B\u017Ek\u00FDch p\u0159\u00EDznak\u016F benign\u00ED hyperplazie prostaty (BHP).\nSn\u00ED\u017Een\u00ED rizika akutn\u00ED retence mo\u010Di (ARM) a chirurgick\u00E9ho v\u00FDkonu u pacient\u016F se st\u0159edn\u011B t\u011B\u017Ek\u00FDmi a\u017E t\u011B\u017Ek\u00FDmi p\u0159\u00EDznaky BHP. \nPro informace o \u00FA\u010Dinc\u00EDch l\u00E9\u010Dby a souborech pacient\u016F zkouman\u00FDch v\u00A0klinick\u00FDch studi\u00EDch nahl\u00E9dn\u011Bte, pros\u00EDm, do bodu 5.1.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasResumedMarketingDate" : [ { "@value" : "2011-12-15" , "@type" : "http://www.w3.org/2001/XMLSchema#date" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasBreakMarketingDate" : [ { "@value" : "2012-05-24" , "@type" : "http://www.w3.org/2001/XMLSchema#date" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 688.3499755859375 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 300.7699890136719 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR CPS MOL 30X0.5MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0016904",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "AVODART 0,5 MG" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/G04CB02" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "VARIA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC148507_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "90" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "0.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Terapie st\u0159edn\u011B t\u011B\u017Ek\u00FDch a\u017E t\u011B\u017Ek\u00FDch p\u0159\u00EDznak\u016F benign\u00ED hyperplazie prostaty (BHP).\nSn\u00ED\u017Een\u00ED rizika akutn\u00ED retence mo\u010Di (ARM) a chirurgick\u00E9ho v\u00FDkonu u pacient\u016F se st\u0159edn\u011B t\u011B\u017Ek\u00FDmi a\u017E t\u011B\u017Ek\u00FDmi p\u0159\u00EDznaky BHP. \nPro informace o \u00FA\u010Dinc\u00EDch l\u00E9\u010Dby a souborech pacient\u016F zkouman\u00FDch v\u00A0klinick\u00FDch studi\u00EDch nahl\u00E9dn\u011Bte, pros\u00EDm, do bodu 5.1.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasResumedMarketingDate" : [ { "@value" : "2008-02-01" , "@type" : "http://www.w3.org/2001/XMLSchema#date" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 2155.889892578125 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 902.2999877929688 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR CPS MOL 90X0.5MG" , "@language" : "cs" } ] }] }